BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35409184)

  • 1. VCAM-1 Targeted Lipopolyplexes as Vehicles for Efficient Delivery of shRNA-Runx2 to Osteoblast-Differentiated Valvular Interstitial Cells; Implications in Calcific Valve Disease Treatment.
    Voicu G; Rebleanu D; Mocanu CA; Tanko G; Droc I; Uritu CM; Pinteala M; Manduteanu I; Simionescu M; Calin M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease.
    Voicu G; Mocanu CA; Safciuc F; Anghelache M; Deleanu M; Cecoltan S; Pinteala M; Uritu CM; Droc I; Simionescu M; Manduteanu I; Calin M
    Mater Today Bio; 2023 Jun; 20():100620. PubMed ID: 37063777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Polyplexes Mediated Transfection of Runx2-shRNA Mitigates the Osteodifferentiation of Human Valvular Interstitial Cells.
    Voicu G; Rebleanu D; Constantinescu CA; Fuior EV; Ciortan L; Droc I; Uritu CM; Pinteala M; Manduteanu I; Simionescu M; Calin M
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32498305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
    Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification.
    Yu C; Li L; Xie F; Guo S; Liu F; Dong N; Wang Y
    Cardiovasc Res; 2018 Jan; 114(1):168-179. PubMed ID: 29016735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
    Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
    J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-138-5p targets RUNX2 to inhibit osteogenic differentiation of aortic valve interstitial cells via Wnt/β-catenin signaling pathway.
    Yan F; Huo Q; Zhang W; Wu T; Dilimulati D; Shi L
    BMC Cardiovasc Disord; 2022 Feb; 22(1):24. PubMed ID: 35109802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End stage renal disease-induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived-matrix vesicles.
    Cui L; Rashdan NA; Zhu D; Milne EM; Ajuh P; Milne G; Helfrich MH; Lim K; Prasad S; Lerman DA; Vesey AT; Dweck MR; Jenkins WS; Newby DE; Farquharson C; Macrae VE
    J Cell Physiol; 2017 Nov; 232(11):2985-2995. PubMed ID: 28369848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling.
    Toshima T; Watanabe T; Narumi T; Otaki Y; Shishido T; Aono T; Goto J; Watanabe K; Sugai T; Takahashi T; Yokoyama M; Kinoshita D; Tamura H; Kato S; Nishiyama S; Arimoto T; Takahashi H; Miyamoto T; Sadahiro M; Watanabe M
    Cardiovasc Res; 2020 Apr; 116(5):983-994. PubMed ID: 31393559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells.
    Zhang M; Liu X; Zhang X; Song Z; Han L; He Y; Xu Z
    J Thorac Cardiovasc Surg; 2014 Mar; 147(3):1073-1080.e2. PubMed ID: 23968872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valvular interstitial cells suppress calcification of valvular endothelial cells.
    Hjortnaes J; Shapero K; Goettsch C; Hutcheson JD; Keegan J; Kluin J; Mayer JE; Bischoff J; Aikawa E
    Atherosclerosis; 2015 Sep; 242(1):251-260. PubMed ID: 26232165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVCAPIR: A Novel Procalcific PIWI-Interacting RNA in Calcific Aortic Valve Disease.
    Han D; Zhou T; Li L; Ma Y; Chen S; Yang C; Ma N; Song M; Zhang S; Wu J; Cao F; Wang Y
    Circulation; 2024 May; 149(20):1578-1597. PubMed ID: 38258575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells.
    Sun JT; Chen YY; Mao JY; Wang YP; Chen YF; Hu X; Yang K; Liu Y
    J Cardiovasc Transl Res; 2019 Dec; 12(6):560-568. PubMed ID: 31367900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted Factors From Proinflammatory Macrophages Promote an Osteoblast-Like Phenotype in Valvular Interstitial Cells.
    Grim JC; Aguado BA; Vogt BJ; Batan D; Andrichik CL; Schroeder ME; Gonzalez-Rodriguez A; Yavitt FM; Weiss RM; Anseth KS
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):e296-e308. PubMed ID: 32938214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT6-mediated Runx2 downregulation inhibits osteogenic differentiation of human aortic valve interstitial cells in calcific aortic valve disease.
    Xiong J; Lin W; Yuan C; Bian J; Diao Y; Xu X; Ni B; Zhang H; Shao Y
    Eur J Pharmacol; 2024 Apr; 968():176423. PubMed ID: 38365109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells.
    Wang Y; Han D; Zhou T; Chen C; Cao H; Zhang JZ; Ma N; Liu C; Song M; Shi J; Jin X; Cao F; Dong N
    Eur Heart J; 2021 Aug; 42(30):2935-2951. PubMed ID: 34179958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role for Galectin-3 in Calcific Aortic Valve Stenosis.
    Sádaba JR; Martínez-Martínez E; Arrieta V; Álvarez V; Fernández-Celis A; Ibarrola J; Melero A; Rossignol P; Cachofeiro V; López-Andrés N
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27815266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2.
    Yang X; Meng X; Su X; Mauchley DC; Ao L; Cleveland JC; Fullerton DA
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):1008-15. PubMed ID: 19664780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrotanshinone I inhibits aortic valve interstitial cell calcification via the SMAD1/5/8/NF-κB/ERK pathway.
    Wang Y; Weng Y; Li X; Huang Q; Xiang Y; Li X; Shi Q
    Biomed Pharmacother; 2021 Jul; 139():111674. PubMed ID: 34243610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered MicroRNA Expression Is Responsible for the Pro-Osteogenic Phenotype of Interstitial Cells in Calcified Human Aortic Valves.
    Song R; Fullerton DA; Ao L; Zhao KS; Reece TB; Cleveland JC; Meng X
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.